QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.027672v1 70/4/1369    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pollenz, R. S. Articles by Dougherty, E. J. Search for Related Content PubMed PubMed Citation Articles by Pollenz, R. S. Articles by Dougherty, E. J.

Role of Endogenous XAP2 Protein on the Localization and Nucleocytoplasmic Shuttling of the Endogenous Mouse Ah^b-1 Receptor in the Presence and Absence of Ligand

Department of Biology, University of South Florida, Tampa, Florida

Studies using transient expression systems have implicated the hepatitis B virus X-associated protein (XAP2) in the control of aryl hydrocarbon receptor (AHR) stability and subcellular location. Studies were performed in Hepa-1 cells to evaluate these functions of XAP2 on the mouse Ah^b-1 receptor under endogenous stoichiometry. The Ah^b-1 receptor is cytoplasmic, and it becomes predominantly nuclear after 30 to 60 min of ligand exposure with minimal degradation. During this time, XAP2 coprecipitates with the AHR, suggesting that it does not affect the nuclear localization of the liganded receptor. Overexpression of XAP2 in Hepa-1 cells does not result in increased association with the endogenous Ah^b-1 complex or influence the receptors cytoplasmic localization. Knockdown of endogenous XAP2 by small interfering RNA results in 90% reduction in the amount of XAP2 associated with the endogenous Ah^b-1 receptor complex. Despite the reduction in XAP2, the unliganded Ah^b-1 receptor complex remains cytoplasmic, although inhibition of nuclear export results in accumulation of the receptor in the nucleus. Truncation of the C-terminal 305 amino acids of the Ah^b-1 receptor (AHR₅₀₀) results in proteins that exhibit a predominantly nuclear localization and remain associated with the same level of endogenous XAP2 as full-length AHRs. Together, these results support a model in which the majority of the unliganded Ah^b-1 receptor complexes are associated with XAP2, and the association prevents dynamic nucleocytoplasmic shuttling in the unliganded state. After ligand binding, XAP2 remains associated with the Ah^b-1 receptor complex, and it does not impair nuclear translocation but may function to limit receptor "transformation".

Received for publication June 6, 2006.

Accepted for publication July 11, 2006.

Address correspondence to: Dr. Richard S. Pollenz, Department of Biology, BSF 110, 4202 E. Fowler Ave., University of South Florida, Tampa, FL 33620. E-mail: pollenz{at}cas.usf.edu

This article has been cited by other articles:

				A. C. Pesatori, A. Baccarelli, D. Consonni, A. Lania, P. Beck-Peccoz, P. A. Bertazzi, and A. Spada Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident Eur. J. Endocrinol., December 1, 2008; 159(6): 699 - 703. [Abstract] [Full Text] [PDF]

				A. Soshilov and M. S. Denison Role of the Per/Arnt/Sim Domains in Ligand-dependent Transformation of the Aryl Hydrocarbon Receptor J. Biol. Chem., November 21, 2008; 283(47): 32995 - 33005. [Abstract] [Full Text] [PDF]

				C. A. Leontiou, M. Gueorguiev, J. van der Spuy, R. Quinton, F. Lolli, S. Hassan, H. S. Chahal, S. C. Igreja, S. Jordan, J. Rowe, et al. The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2390 - 2401. [Abstract] [Full Text] [PDF]

				T. Suzuki and K. Nohara Regulatory Factors Involved in Species-specific Modulation of Arylhydrocarbon Receptor (AhR)-dependent Gene Expression in Humans and Mice J. Biochem., October 1, 2007; 142(4): 443 - 452. [Abstract] [Full Text] [PDF]

				X. Chang, Y. Fan, S. Karyala, S. Schwemberger, C. R. Tomlinson, M. A. Sartor, and A. Puga Ligand-Independent Regulation of Transforming Growth Factor {beta}1 Expression and Cell Cycle Progression by the Aryl Hydrocarbon Receptor Mol. Cell. Biol., September 1, 2007; 27(17): 6127 - 6139. [Abstract] [Full Text] [PDF]

				S. E. Eltom and Y. Dale Response to Comments on "Calpain Mediates the Dioxin-Induced Activation and Down-Regulation of the Aryl Hydrocarbon Receptor" Mol. Pharmacol., January 1, 2007; 71(1): 386 - 387. [Full Text] [PDF]

				B. D. Hollingshead, R. D. Patel, and G. H. Perdew Endogenous Hepatic Expression of the Hepatitis B Virus X-Associated Protein 2 Is Adequate for Maximal Association with Aryl Hydrocarbon Receptor-90-kDa Heat Shock Protein Complexes Mol. Pharmacol., December 1, 2006; 70(6): 2096 - 2107. [Abstract] [Full Text] [PDF]